gadofosveset trisodium has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberich-Bayarri, A; Blasco, G; Daunis-I-Estadella, J; Essig, M; Hernández, D; Jain, R; Mateu, G; Pedraza, S; Puig, J; Puigdemont, M; Remollo, S; Sánchez-González, J; Wintermark, M | 1 |
| Bergmann, K; Bernado, L; Blasco, G; Daunis-I-Estadella, J; Essig, M; Joly, C; Laguillo, G; Pedraza, S; Puig, J; Quiles, AM; Remollo, S; Sánchez-González, J | 1 |
1 trial(s) available for gadofosveset trisodium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Albumin-binding MR blood pool contrast agent improves diagnostic performance in human brain tumour: comparison of two contrast agents for glioblastoma.
Topics: Albumins; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2013 |
1 other study(ies) available for gadofosveset trisodium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.
Topics: Biomarkers; Brain Neoplasms; Female; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Prospective Studies; Survival Rate | 2016 |